Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009

Authors: Boon How Chew, Ismail Mastura, Sazlina Shariff-Ghazali, Ping Yein Lee, Ai Theng Cheong, Zaiton Ahmad, Sri Wahyu Taher, Jamaiyah Haniff, Feisul Idzwan Mustapha, Mohd Adam Bujang

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Uncontrolled blood pressure (BP) is a significant contributor of morbidity and even mortality in type 2 diabetes (T2D) patients. This study was done to determine the significant determinants of uncontrolled blood pressure in T2D patients in Malaysia.

Methods

Between 1st January 2009 to 31st December 2009, data from 70 889 patients with Type 2 diabetes was obtained from the Adult Diabetes Control and Management Registry for analysis; 303 centers participated in the study. Their demographic characteristics, the nature of their diabetes, their state of hypertension, treatment modalities, risk factors, and complications are described. Based on their most recent BP values, subjects were divided into controlled BP and uncontrolled BP and their clinical determinants compared. Independent determinants were identified using multivariate logistic regression.

Results

The mean age of patients at diagnosis of diabetes was 52.3 ± 11.1 years old. Most were women (59.0 %) and of Malay ethnicity (61.9 %). The mean duration of diabetes was 5.9 ± 5.6 years. A total of 57.4 % were hypertensive. Of the 56 503 blood pressure (BP) measured, 13 280 (23.5 %) patients had BP <130/80 mmHg. Eighteen percent was on > two anti-hypertensive agents. Health clinics without doctor, older age (≥ 50 years old), shorter duration of diabetes (< 5 years), Malay, overweight were determinants for uncontrolled blood pressure (BP ≥130/80 mmHg). Patients who were on anti-hypertensive agent/s were 2.7 times more likely to have BP ≥130/80 mmHg. Type 2 diabetes patients who had ischaemic heart disease or nephropathy were about 20 % and 15 % more likely to have their blood pressure treated to target respectively.

Conclusions

Major independent determinants of uncontrolled BP in our group of T2D patients were Malay ethnicity, older age, recent diagnosis of diabetes, overweight and follow-up at health clinics without a doctor and possibly the improper use of anti hypertensive agent. More effort, education and resources, especially in the primary health care centres are needed to improve hypertensive care among our patients with diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Williams B: The Hypertension in Diabetes Study (HDS): a catalyst for change. Diabet Med. 2008, 25 (Suppl 2): 13-19.CrossRefPubMed Williams B: The Hypertension in Diabetes Study (HDS): a catalyst for change. Diabet Med. 2008, 25 (Suppl 2): 13-19.CrossRefPubMed
2.
go back to reference Joffres MR, Hamet P, MacLean DR, L’Italien GJ, Fodor G: Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001, 14 (11 Pt 1): 1099-1105.CrossRefPubMed Joffres MR, Hamet P, MacLean DR, L’Italien GJ, Fodor G: Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001, 14 (11 Pt 1): 1099-1105.CrossRefPubMed
3.
go back to reference Hypertension in Diabetes Study G: HDS 1: Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993, 11 (3): 309-317. 10.1097/00004872-199303000-00012.CrossRef Hypertension in Diabetes Study G: HDS 1: Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993, 11 (3): 309-317. 10.1097/00004872-199303000-00012.CrossRef
4.
go back to reference McLean DL, Simpson SH, McAlister FA, Tsuyuki RT: Treatment and blood pressure control in 47,964 people with diabetes and hypertension: A systematic review of observational studies. Can J Cardiol. 2006, 22 (10): 855-860. 10.1016/S0828-282X(06)70304-X.PubMedCentralCrossRefPubMed McLean DL, Simpson SH, McAlister FA, Tsuyuki RT: Treatment and blood pressure control in 47,964 people with diabetes and hypertension: A systematic review of observational studies. Can J Cardiol. 2006, 22 (10): 855-860. 10.1016/S0828-282X(06)70304-X.PubMedCentralCrossRefPubMed
5.
go back to reference Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NRC: Cardiovascular Outcomes in Framingham Participants With Diabetes: The Importance of Blood Pressure. Hypertension. 2011, 57 (5): 891-897. 10.1161/HYPERTENSIONAHA.110.162446.PubMedCentralCrossRefPubMed Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NRC: Cardiovascular Outcomes in Framingham Participants With Diabetes: The Importance of Blood Pressure. Hypertension. 2011, 57 (5): 891-897. 10.1161/HYPERTENSIONAHA.110.162446.PubMedCentralCrossRefPubMed
6.
go back to reference Williams B: Hypertension in Diabetes. 2003, Martin Dunitz Publisher, London and New York, 99-108.CrossRef Williams B: Hypertension in Diabetes. 2003, Martin Dunitz Publisher, London and New York, 99-108.CrossRef
7.
go back to reference Nosadini R: Blood glucose in relation to blood pressure control as risk factors in the progression of renal damage in type 2 diabetes. International Congress Series. 2003, 1253: 295-299.CrossRef Nosadini R: Blood glucose in relation to blood pressure control as risk factors in the progression of renal damage in type 2 diabetes. International Congress Series. 2003, 1253: 295-299.CrossRef
8.
go back to reference Fowler MJ: Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes. 2008, 26 (2): 77-82. 10.2337/diaclin.26.2.77.CrossRef Fowler MJ: Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes. 2008, 26 (2): 77-82. 10.2337/diaclin.26.2.77.CrossRef
9.
go back to reference Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000, 321 (7258): 412-419. 10.1136/bmj.321.7258.412.PubMedCentralCrossRefPubMed Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000, 321 (7258): 412-419. 10.1136/bmj.321.7258.412.PubMedCentralCrossRefPubMed
10.
go back to reference Raikou M, Gray A, Briggs A, Stevens R, Cull C: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ. 1998, 317 (7160): 720-726. 10.1136/bmj.317.7160.720.CrossRef Raikou M, Gray A, Briggs A, Stevens R, Cull C: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ. 1998, 317 (7160): 720-726. 10.1136/bmj.317.7160.720.CrossRef
11.
go back to reference Clarke P, Gray A, Briggs A, Stevens R, Matthews D, Holman R: Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia. 2005, 48 (5): 868-877. 10.1007/s00125-005-1717-3.CrossRefPubMed Clarke P, Gray A, Briggs A, Stevens R, Matthews D, Holman R: Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia. 2005, 48 (5): 868-877. 10.1007/s00125-005-1717-3.CrossRefPubMed
12.
go back to reference Ibrahim WN, Aljunid S, Ismail A: Cost of Type 2 Diabetes Mellitus in Selected Developing Countries. Malaysian Journal of Public Health Medicine. 2010, 10 (2): 68-71. Ibrahim WN, Aljunid S, Ismail A: Cost of Type 2 Diabetes Mellitus in Selected Developing Countries. Malaysian Journal of Public Health Medicine. 2010, 10 (2): 68-71.
13.
go back to reference Ismail Mastura, Chew BH, Lee PY, Cheong AT, Sazlina SG, Jamaiyah H, Alwi SARS, Wahyu TS, Zaiton A: Control and Treatment Profiles of 70,889 Adult Type 2 Diabetes Mellitus Patients in Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011, 3 (1): 98-113. Ismail Mastura, Chew BH, Lee PY, Cheong AT, Sazlina SG, Jamaiyah H, Alwi SARS, Wahyu TS, Zaiton A: Control and Treatment Profiles of 70,889 Adult Type 2 Diabetes Mellitus Patients in Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011, 3 (1): 98-113.
14.
go back to reference Awin N: A Review of Primary Health Care in Malaysia- A Report for the World Health Organization Western Pacific Region. 2000, Ministry of Health, Malaysia, 6-23. Awin N: A Review of Primary Health Care in Malaysia- A Report for the World Health Organization Western Pacific Region. 2000, Ministry of Health, Malaysia, 6-23.
15.
go back to reference Noor Ghani S, Yadav H: Health Care in Malaysia. 2008, University of Malaya Press, Kuala Lumpur Noor Ghani S, Yadav H: Health Care in Malaysia. 2008, University of Malaya Press, Kuala Lumpur
16.
go back to reference Ministry Of Health: MOH Drug Formulary, vol. 3/2011. 2011, Putrajaya: Ministry of Health, Malaysia Ministry Of Health: MOH Drug Formulary, vol. 3/2011. 2011, Putrajaya: Ministry of Health, Malaysia
17.
go back to reference Ministry of Health Malaysia: Management of Type 2 Diabetes Mellitus. 2009, Technology, Health Section, Assessment Division, Medical Development, Putrajaya Ministry of Health Malaysia: Management of Type 2 Diabetes Mellitus. 2009, Technology, Health Section, Assessment Division, Medical Development, Putrajaya
18.
go back to reference American Diabetes Association: Treatment of Hypertension in Adults With Diabetes. Diabetes Care. 2003, 26 (suppl 1): s80-s82. American Diabetes Association: Treatment of Hypertension in Adults With Diabetes. Diabetes Care. 2003, 26 (suppl 1): s80-s82.
19.
go back to reference Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdóttir S, for the Steering Committee of the Swedish National Diabetes R: The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003. Diabet Med. 2005, 22 (10): 1420-1426. 10.1111/j.1464-5491.2005.01648.x.CrossRefPubMed Eliasson B, Cederholm J, Nilsson P, Gudbjörnsdóttir S, for the Steering Committee of the Swedish National Diabetes R: The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003. Diabet Med. 2005, 22 (10): 1420-1426. 10.1111/j.1464-5491.2005.01648.x.CrossRefPubMed
20.
go back to reference Sazlina SG, Zaiton A, Ong I: A Clinical Audit on Diabetes Care in Two Urban Public Primary Care Clinics in Malaysia. Malaysian Journal of Medicine and Health Sciences. 2010, 6 (1): 101-109. Sazlina SG, Zaiton A, Ong I: A Clinical Audit on Diabetes Care in Two Urban Public Primary Care Clinics in Malaysia. Malaysian Journal of Medicine and Health Sciences. 2010, 6 (1): 101-109.
21.
go back to reference Sabanayagam C, Shankar A, Saw SM, Tai ES, Lim SC, Lee JJ-M, Wong TY: Prevalence of Diabetes Mellitus, Glycemic Control, and Associated Factors in a Malay Population in Singapore. Asia Pac J Public Health. 2009, 21 (4): 385-398. 10.1177/1010539509343958.CrossRefPubMed Sabanayagam C, Shankar A, Saw SM, Tai ES, Lim SC, Lee JJ-M, Wong TY: Prevalence of Diabetes Mellitus, Glycemic Control, and Associated Factors in a Malay Population in Singapore. Asia Pac J Public Health. 2009, 21 (4): 385-398. 10.1177/1010539509343958.CrossRefPubMed
22.
go back to reference Howteerakul N, Suwannapong N, Rittichu C, Rawdaree P: Adherence to Regimens and Glycemic Control of Patients with Type 2 Diabetes Attending a Tertiary Hospital Clinic. Asia Pac J Public Health. 2007, 19 (1): 43-49. 10.1177/10105395070190010901.CrossRefPubMed Howteerakul N, Suwannapong N, Rittichu C, Rawdaree P: Adherence to Regimens and Glycemic Control of Patients with Type 2 Diabetes Attending a Tertiary Hospital Clinic. Asia Pac J Public Health. 2007, 19 (1): 43-49. 10.1177/10105395070190010901.CrossRefPubMed
23.
go back to reference Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, et al: Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J. 2006, 27 (24): 2982-2988. 10.1093/eurheartj/ehl403.CrossRefPubMed Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, McInnes G, et al: Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J. 2006, 27 (24): 2982-2988. 10.1093/eurheartj/ehl403.CrossRefPubMed
24.
go back to reference Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005, 365 (9457): 434-441.CrossRefPubMed Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005, 365 (9457): 434-441.CrossRefPubMed
25.
go back to reference Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al: Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus. Diabetes Care. 2007, 30 (1): 162-172. 10.2337/dc07-9917.CrossRefPubMed Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al: Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus. Diabetes Care. 2007, 30 (1): 162-172. 10.2337/dc07-9917.CrossRefPubMed
26.
go back to reference Boer-Martins L, Figueiredo V, Demacq C, Martins L, Consolin-Colombo F, Figueiredo M, Cannavan F, Moreno H: Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol. 2011, 10 (1): 24-10.1186/1475-2840-10-24.PubMedCentralCrossRefPubMed Boer-Martins L, Figueiredo V, Demacq C, Martins L, Consolin-Colombo F, Figueiredo M, Cannavan F, Moreno H: Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol. 2011, 10 (1): 24-10.1186/1475-2840-10-24.PubMedCentralCrossRefPubMed
27.
go back to reference Leosdottir M, Willenheimer R, Persson M, Nilsson P: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmo Preventive Project. Cardiovasc Diabetol. 2011, 10 (1): 118-10.1186/1475-2840-10-118.PubMedCentralCrossRefPubMed Leosdottir M, Willenheimer R, Persson M, Nilsson P: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmo Preventive Project. Cardiovasc Diabetol. 2011, 10 (1): 118-10.1186/1475-2840-10-118.PubMedCentralCrossRefPubMed
28.
go back to reference Duggirala MK, Cuddihy RM, Cuddihy M-T, Naessens JM, Cha SS, Mandrekar JN, Leibson CL: Predictors of Blood Pressure Control in Patients With Diabetes and Hypertension Seen in Primary Care Clinics. Am J Hypertens. 2005, 18 (6): 833-838. 10.1016/j.amjhyper.2004.12.016.CrossRefPubMed Duggirala MK, Cuddihy RM, Cuddihy M-T, Naessens JM, Cha SS, Mandrekar JN, Leibson CL: Predictors of Blood Pressure Control in Patients With Diabetes and Hypertension Seen in Primary Care Clinics. Am J Hypertens. 2005, 18 (6): 833-838. 10.1016/j.amjhyper.2004.12.016.CrossRefPubMed
29.
go back to reference Gudbjörnsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM, on behalf of the Swedish National Diabetes R: Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Diabet Med. 2009, 26 (1): 53-60. 10.1111/j.1464-5491.2008.02633.x.CrossRefPubMed Gudbjörnsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM, on behalf of the Swedish National Diabetes R: Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Diabet Med. 2009, 26 (1): 53-60. 10.1111/j.1464-5491.2008.02633.x.CrossRefPubMed
30.
go back to reference Konzem SL, Devore VS, Bauer DW: Controlling hypertension in patients with diabetes. Am Fam Physician. 2002, 66 (7): 1209-1214.PubMed Konzem SL, Devore VS, Bauer DW: Controlling hypertension in patients with diabetes. Am Fam Physician. 2002, 66 (7): 1209-1214.PubMed
31.
go back to reference Neldam S, Lang M, Jones R, On behalf of the T-I: Telmisartan and Amlodipine Single-Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA-5 Study. J Clin Hypertens. 2011, 13 (7): 459-466. 10.1111/j.1751-7176.2011.00468.x.CrossRef Neldam S, Lang M, Jones R, On behalf of the T-I: Telmisartan and Amlodipine Single-Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA-5 Study. J Clin Hypertens. 2011, 13 (7): 459-466. 10.1111/j.1751-7176.2011.00468.x.CrossRef
32.
go back to reference Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005, 366 (9489): 895-906. 10.1016/S0140-6736(05)67185-1.CrossRefPubMed Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005, 366 (9489): 895-906. 10.1016/S0140-6736(05)67185-1.CrossRefPubMed
33.
go back to reference Abdulameer SA, Sahib MN, Aziz NA, Hassan Y, Alrazzaq HA, Ismail O: Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study. Patient Prefer Adherence. 2012, 6: 101-108.PubMedCentralCrossRefPubMed Abdulameer SA, Sahib MN, Aziz NA, Hassan Y, Alrazzaq HA, Ismail O: Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study. Patient Prefer Adherence. 2012, 6: 101-108.PubMedCentralCrossRefPubMed
34.
go back to reference Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med. 2010, 362 (17): 1575-1585. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med. 2010, 362 (17): 1575-1585.
35.
go back to reference Tan MY, Magarey JM, Chee SS, Lee LF, Tan MH: A brief structured education programme enhances self-care practices and improves glycaemic control in Malaysians with poorly controlled diabetes. Health Educ Res. 2011, 26 (5): 896-907. 10.1093/her/cyr047.CrossRefPubMed Tan MY, Magarey JM, Chee SS, Lee LF, Tan MH: A brief structured education programme enhances self-care practices and improves glycaemic control in Malaysians with poorly controlled diabetes. Health Educ Res. 2011, 26 (5): 896-907. 10.1093/her/cyr047.CrossRefPubMed
36.
go back to reference Grant RW, Cagliero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB: Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004, 21 (2): 150-155. 10.1111/j.1464-5491.2004.01095.x.CrossRefPubMed Grant RW, Cagliero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB: Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004, 21 (2): 150-155. 10.1111/j.1464-5491.2004.01095.x.CrossRefPubMed
37.
go back to reference Rohana D, Wan Norlida WI, Nor Azwany Y, Mazlan A, Zawiya D, Che Kamaludin CA, Cs CG: Economic Evaluation of Type 2 Diabetes Management at the Malaysian Ministry of Health Primary Care Clinics, in Machang, Kelantan. Malaysian Journal of Public Health Medicine. 2007, 7 (1): 5-13. Rohana D, Wan Norlida WI, Nor Azwany Y, Mazlan A, Zawiya D, Che Kamaludin CA, Cs CG: Economic Evaluation of Type 2 Diabetes Management at the Malaysian Ministry of Health Primary Care Clinics, in Machang, Kelantan. Malaysian Journal of Public Health Medicine. 2007, 7 (1): 5-13.
38.
go back to reference National Healthcare Establishments & Workforce Statistics ( Primary Care ) 2008–2009. 2011, Clinical Research Centre, Ministry of Health, Malaysia, Kuala Lumpur National Healthcare Establishments & Workforce Statistics ( Primary Care ) 2008–2009. 2011, Clinical Research Centre, Ministry of Health, Malaysia, Kuala Lumpur
39.
go back to reference Elasy T: Improving Diabetes Outcomes: Beyond Glucocentricity. Clin Diabetes. 2008, 26 (1): 1-2. 10.2337/diaclin.26.1.1.CrossRef Elasy T: Improving Diabetes Outcomes: Beyond Glucocentricity. Clin Diabetes. 2008, 26 (1): 1-2. 10.2337/diaclin.26.1.1.CrossRef
40.
go back to reference Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine R, Hall J, Lacey K, MacDonald I, Burge F, Natarajan N, et al: Hypertension and type 2 diabetes: What family physicians can do to improve control of blood pressure - an observational study. BMC Fam Pract. 2011, 12 (1): 86-10.1186/1471-2296-12-86.PubMedCentralCrossRefPubMed Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine R, Hall J, Lacey K, MacDonald I, Burge F, Natarajan N, et al: Hypertension and type 2 diabetes: What family physicians can do to improve control of blood pressure - an observational study. BMC Fam Pract. 2011, 12 (1): 86-10.1186/1471-2296-12-86.PubMedCentralCrossRefPubMed
41.
go back to reference Chan GC, Teng CL: Primary care doctors' perceptions towards evidence-based medicine in Melaka State: a questionnaire study. Med J Malaysia. 2005, 60 (2): 130-133.PubMed Chan GC, Teng CL: Primary care doctors' perceptions towards evidence-based medicine in Melaka State: a questionnaire study. Med J Malaysia. 2005, 60 (2): 130-133.PubMed
42.
go back to reference Kaissi AA, Parchman M: Organizational Factors Associated With Self-management Behaviors in Diabetes Primary Care Clinics. Diabetes Educ. 2009, 35 (5): 843-850. 10.1177/0145721709342901.CrossRefPubMed Kaissi AA, Parchman M: Organizational Factors Associated With Self-management Behaviors in Diabetes Primary Care Clinics. Diabetes Educ. 2009, 35 (5): 843-850. 10.1177/0145721709342901.CrossRefPubMed
43.
go back to reference Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H, for the CIII: Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ. 2009, 181 (1–2): 37-44.PubMedCentralCrossRefPubMed Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H, for the CIII: Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ. 2009, 181 (1–2): 37-44.PubMedCentralCrossRefPubMed
44.
go back to reference Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA: Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes. Diabetes Care. 2011, 34 (1): 20-26. 10.2337/dc10-1294.PubMedCentralCrossRefPubMed Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA: Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes. Diabetes Care. 2011, 34 (1): 20-26. 10.2337/dc10-1294.PubMedCentralCrossRefPubMed
45.
go back to reference Simkin-Silverman LR, Conroy MB, Bhargava T, McTigue KM: Development of an Online Diabetes Prevention Lifestyle Intervention Coaching Protocol for Use in Primary Care Practice. Diabetes Educ. 2011, 37 (2): 263-268. 10.1177/0145721710396587.CrossRefPubMed Simkin-Silverman LR, Conroy MB, Bhargava T, McTigue KM: Development of an Online Diabetes Prevention Lifestyle Intervention Coaching Protocol for Use in Primary Care Practice. Diabetes Educ. 2011, 37 (2): 263-268. 10.1177/0145721710396587.CrossRefPubMed
46.
go back to reference Lai P, Chua SS, Tan CH, Chan SP: Validation of the Diabetes, Hypertension and Hyperlipidemia (DHL) knowledge instrument in Malaysia. BMC Med Res Methodol. 2012, 12 (1): 18-10.1186/1471-2288-12-18.PubMedCentralCrossRefPubMed Lai P, Chua SS, Tan CH, Chan SP: Validation of the Diabetes, Hypertension and Hyperlipidemia (DHL) knowledge instrument in Malaysia. BMC Med Res Methodol. 2012, 12 (1): 18-10.1186/1471-2288-12-18.PubMedCentralCrossRefPubMed
47.
go back to reference BoonHow C, Theng CA, Ismail M, Rahman SASA: Diabetic Hypertensive Control And Treatment: A Descriptive Report From The Audit Diabetes Control And Management (ADCM) Registry. Malaysian Family Physician. 2010, 5 (3): 134-138. BoonHow C, Theng CA, Ismail M, Rahman SASA: Diabetic Hypertensive Control And Treatment: A Descriptive Report From The Audit Diabetes Control And Management (ADCM) Registry. Malaysian Family Physician. 2010, 5 (3): 134-138.
48.
go back to reference Larrañaga I, Arteagoitia JM, Rodriguez JL, Gonzalez F, Esnaola S, Piniés JA, the Sentinel Practice Network of the Basque C: Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain. Diabet Med. 2005, 22 (8): 1047-1053. 10.1111/j.1464-5491.2005.01598.x.CrossRefPubMed Larrañaga I, Arteagoitia JM, Rodriguez JL, Gonzalez F, Esnaola S, Piniés JA, the Sentinel Practice Network of the Basque C: Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain. Diabet Med. 2005, 22 (8): 1047-1053. 10.1111/j.1464-5491.2005.01598.x.CrossRefPubMed
49.
go back to reference Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML: Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry. 2005, 13 (9): 748-755.PubMedCentralCrossRefPubMed Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML: Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry. 2005, 13 (9): 748-755.PubMedCentralCrossRefPubMed
Metadata
Title
Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009
Authors
Boon How Chew
Ismail Mastura
Sazlina Shariff-Ghazali
Ping Yein Lee
Ai Theng Cheong
Zaiton Ahmad
Sri Wahyu Taher
Jamaiyah Haniff
Feisul Idzwan Mustapha
Mohd Adam Bujang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-54

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue